Unique Ingredient Identifier QTT17582CB is listed as a ingredient substance
| RN | 7647-01-0 |
| EC | 231-595-7 |
| NCIT | C76716 |
| RXCUI | 5486 |
| MF | ClH |
| INCHI KEY | VEXZGXHMUGYJMC-UHFFFAOYSA-N |
| SMILES | Cl |
UNII QTT17582CB HYDROCHLORIC ACID is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,CNBLK INTRATHECAL | INJECTION | ADJPH |
| AN,INFILTRATION | INJECTABLE | ADJPH |
| AN,INFILTRATION | INJECTION | 1.36 % |
| AN,SYMPATHETIC NBLK | INJECTION | ADJPH |
| AURICULAR (OTIC) | SOLUTION | 0.37 % |
| AURICULAR (OTIC) | SUSPENSION | 0.044 % |
| CAUDAL BLOCK | INJECTABLE | ADJPH |
| CAUDAL BLOCK | INJECTION | ADJPH |
| DENTAL | INJECTABLE | ADJPH |
| DENTAL | SOLUTION | ADJPH |
| EPIDURAL | INJECTION | ADJPH |
| EPIDURAL | INJECTION, SOLUTION | ADJ PH |
| EPIDURAL | LIQUID, WATER, STERILE, FOR INJECTION | ADJPH |
| EPIDURAL | SOLUTION | ADJPH |
| EPIDURAL | SOLUTION, INJECTION | ADJPH |
| EXTRACORPOREAL | INJECTION | ADJPH |
| EXTRACORPOREAL | SOLUTION | ADJPH |
| IM - IV | INJECTABLE | 0.025 % |
| IM - IV | INJECTION | 3.06 % |
| IM - IV | INJECTION | ADJPH |
| IM - IV | INJECTION, SOLUTION | ADJPH |
| IM - IV | LIQUID, WATER, STERILE, FOR INJECTION | NA |
| IM - IV | POWDER, FOR INJECTION SOLUTION | ADJPH |
| IM - IV | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJPH |
| IM - IV | SOLUTION, INJECTION | ADJPH |
| IM - IV - SC | INJECTION | ADJPH |
| IM - IV - SC | POWDER, FOR INJECTION SOLUTION | ADJPH |
| IM - IV - SC | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJPH |
| IM - IV - SC | SOLUTION, INJECTION | ADJPH |
| IM - SC | INJECTION | ADJPH |
| IM - SC | INJECTION, SUSTAINED ACTION | NA |
| IM - SC | POWDER, FOR INJECTION SOLUTION | ADJPH |
| INFILTRATION | INJECTION | 0.37 % |
| INFILTRATION | INJECTION | ADJ PH |
| INFILTRATION | INJECTION, SOLUTION | ADJ PH |
| INFILTRATION | SOLUTION, INJECTION | ADJPH |
| INHALATION | AEROSOL, METERED | 1.72 % |
| INHALATION | AEROSOL, SPRAY | 1.5 % |
| INHALATION | SOLUTION | 3.5 % |
| INHALATION | SOLUTION | ADJPH |
| INHALATION | SOLUTION | ADJ PH |
| INHALATION | SOLUTION, FOR INHALATION | ADJPH |
| INHALATION | SPRAY | ADJPH |
| INJECTION | INJECTION | ADJ PH |
| INJECTION | INJECTION, SOLUTION | ADJ PH |
| INTERSTITIAL | INJECTION | ADJPH |
| INTRA-AMNIOTIC | INJECTION | ADJPH |
| INTRA-ARTERIAL | INJECTABLE | ADJPH |
| INTRA-ARTERIAL | INJECTION | ADJPH |
| INTRA-ARTERIAL | POWDER, FOR INJECTION SOLUTION | ADJPH |
| INTRA-ARTERIAL | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJPH |
| INTRA-ARTERIAL | SOLUTION, INJECTION | ADJPH |
| INTRA-ARTERIAL | SUSPENSION, INJECTION | ADJ PH |
| INTRA-ARTICULAR | INJECTABLE | ADJPH |
| INTRA-ARTICULAR | INJECTION | ADJ PH |
| INTRA-ARTICULAR | INJECTION | ADJPH |
| INTRABURSAL | INJECTION | ADJPH |
| INTRACARDIAC | INJECTION | ADJPH |
| INTRACARDIAC | SOLUTION, INJECTION | ADJPH |
| INTRACAUDAL | INJECTION | NA |
| INTRACAUDAL | INJECTION, SOLUTION | ADJ PH |
| INTRACAVITARY | INJECTION | ADJPH |
| INTRACAVITARY | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJPH |
| INTRADERMAL | INJECTION | ADJPH |
| INTRADERMAL | POWDER, FOR INJECTION SOLUTION | ADJPH |
| INTRALESIONAL | INJECTABLE | ADJPH |
| INTRALESIONAL | INJECTION | ADJPH |
| INTRALESIONAL | INJECTION, SUSTAINED ACTION | ADJPH |
| INTRALESIONAL | SUSPENSION, INJECTION | ADJPH |
| INTRAMUSCULAR | INJECTABLE | 8 %V/V |
| INTRAMUSCULAR | INJECTION | ADJ PH |
| INTRAMUSCULAR | INJECTION | ADJPH |
| INTRAMUSCULAR | INJECTION, SOLUTION | ADJ PH |
| INTRAMUSCULAR | INJECTION, SOLUTION | ADJPH |
| INTRAMUSCULAR | INJECTION, SUSPENSION | ADJ PH |
| INTRAMUSCULAR | INJECTION, SUSTAINED ACTION | ADJPH |
| INTRAMUSCULAR | LIQUID | NA |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | ADJPH |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJPH |
| INTRAMUSCULAR | SOLUTION | ADJ PH |
| INTRAMUSCULAR | SOLUTION, INJECTION | 0.61 %W/V |
| INTRAMUSCULAR | SUSPENSION, INJECTION | ADJPH |
| INTRAOCULAR | SOLUTION | ADJPH |
| INTRAPERITONEAL | INJECTION | ADJPH |
| INTRAPERITONEAL | SOLUTION | ADJPH |
| INTRAPLEURAL | INJECTION | ADJPH |
| INTRASPINAL | INJECTION | ADJPH |
| INTRASYNOVIAL | INJECTABLE | ADJPH |
| INTRASYNOVIAL | INJECTION | ADJPH |
| INTRASYNOVIAL | INJECTION, SUSTAINED ACTION | ADJPH |
| INTRASYNOVIAL | SUSPENSION, INJECTION | ADJPH |
| INTRATHECAL | INJECTABLE | ADJPH |
| INTRATHECAL | INJECTION | ADJPH |
| INTRATHECAL | POWDER, FOR INJECTION SOLUTION | ADJPH |
| INTRATHECAL | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJPH |
| INTRATHECAL | SOLUTION | ADJPH |
| INTRATHECAL | SOLUTION, INJECTION | ADJPH |
| INTRATRACHEAL | POWDER, FOR SUSPENSION | ADJPH |
| INTRATRACHEAL | SUSPENSION | ADJPH |
| INTRATUMOR | INJECTABLE | ADJPH |
| INTRATUMOR | INJECTION | ADJPH |
| INTRATUMOR | POWDER, FOR INJECTION SOLUTION | ADJPH |
| INTRATYMPANIC | SUSPENSION | 0.14 %W/W |
| INTRAVASCULAR | INJECTION | ADJPH |
| INTRAVASCULAR | SOLUTION | ADJPH |
| INTRAVENOUS | INJECTABLE | 8 % |
| INTRAVENOUS | INJECTABLE | ADJ PH |
| INTRAVENOUS | INJECTION | 14.87 MG/1ML |
| INTRAVENOUS | INJECTION | ADJ PH |
| INTRAVENOUS | INJECTION | ADJPH |
| INTRAVENOUS | INJECTION | QS |
| INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSP | ADJPH |
| INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 0.85 % |
| INTRAVENOUS | INJECTION, SOLUTION | ADJ PH |
| INTRAVENOUS | INJECTION, SOLUTION | ADJPH |
| INTRAVENOUS | INJECTION, SUSPENSION | ADJPH |
| INTRAVENOUS | INJECTION, SUSPENSION, LIPOSOMAL | ADJPH |
| INTRAVENOUS | LIQUID | ADJPH |
| INTRAVENOUS | LIQUID | ADJ PH |
| INTRAVENOUS | LIQUID, WATER, STERILE, FOR INJECTION | NA |
| INTRAVENOUS | POWDER | ADJPH |
| INTRAVENOUS | POWDER FOR INJECTION DOSAGE FORM | ADJ PH |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | ADJ PH |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | ADJPH |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 16 % |
| INTRAVENOUS | SOLUTION | 1.83 % |
| INTRAVENOUS | SOLUTION | ADJ PH |
| INTRAVENOUS | SOLUTION, CONCENTRATE | ADJPH |
| INTRAVENOUS | SOLUTION, INJECTION | ADJPH |
| INTRAVENOUS | SOLUTION, LIQUID | ADJPH |
| INTRAVENOUS INFUSION | INJECTION | ADJPH |
| INTRAVENOUS INFUSION | POWDER | ADJPH |
| INTRAVESICAL | SOLUTION, INJECTION | 15.7 % |
| INTRAVITREAL | INJECTABLE | ADJPH |
| INTRAVITREAL | INJECTION | ADJPH |
| INTRAVITREAL | SUSPENSION, INJECTION | ADJPH |
| IONTOPHORESIS | SOLUTION | ADJPH |
| IRRIGATION | SOLUTION | ADJPH |
| IV - SC | INJECTION | ADJPH |
| IV - SC | POWDER, FOR INJECTION SOLUTION | ADJPH |
| IV - SC | SOLUTION, INJECTION | ADJPH |
| IV(INFUSION) | INFUSION | ADJPH |
| IV(INFUSION) | INJECTABLE | NA |
| IV(INFUSION) | INJECTION | ADJPH |
| IV(INFUSION) | INJECTION, LIPOSOMAL | ADJPH |
| IV(INFUSION) | LIQUID | ADJPH |
| IV(INFUSION) | LIQUID, WATER, STERILE, FOR INJECTION | ADJPH |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | ADJPH |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJPH |
| IV(INFUSION) | POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED | 0.42 % |
| IV(INFUSION) | SOLUTION | ADJPH |
| IV(INFUSION) | SOLUTION, INJECTION | 12.7 % |
| IV(INFUSION) | SOLUTION, INJECTION | ADJPH |
| NASAL | SOLUTION | 0.25 % |
| NASAL | SOLUTION, SPRAY | ADJPH |
| NASAL | SPRAY | ADJPH |
| NASAL | SPRAY, METERED | ADJPH |
| NERVE BLOCK | INJECTABLE | ADJPH |
| NERVE BLOCK | INJECTION | 1.36 % |
| NERVE BLOCK | SOLUTION, INJECTION | ADJPH |
| OPHTHALMIC | EMULSION | ADJ PH |
| OPHTHALMIC | GEL | ADJPH |
| OPHTHALMIC | POWDER, FOR SOLUTION | ADJPH |
| OPHTHALMIC | SOLUTION | 2.5 MG/1ML |
| OPHTHALMIC | SOLUTION | 1.06 % |
| OPHTHALMIC | SOLUTION | ADJ PH |
| OPHTHALMIC | SOLUTION, DROPS | ADJ PH |
| OPHTHALMIC | SOLUTION, IRRIGATION | ADJPH |
| OPHTHALMIC | SOLUTION/ DROPS | ADJ PH |
| OPHTHALMIC | SOLUTION/DROPS | ADJPH |
| OPHTHALMIC | SUSPENSION | ADJPH |
| OPHTHALMIC | SUSPENSION, DROPS | ADJPH |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | ADJPH |
| ORAL | CONCENTRATE | 0.62 % |
| ORAL | LIQUID | 0.00375 ML/ML |
| ORAL | LIQUID | 0.002 MG/5ML |
| ORAL | POWDER, FOR SUSPENSION | 0.125 g/236mL |
| ORAL | SOLUTION | 9.51 % |
| ORAL | SOLUTION | ADJ PH |
| ORAL | SOLUTION, FOR INHALATION | ADJPH |
| ORAL | SPRAY | 2.49 MG/1SPR |
| ORAL | SUSPENSION | 2 % |
| ORAL | SUSPENSION, EXTENDED RELEASE | ADJPH |
| ORAL | SYRUP | 2.03 MG/1ML |
| ORAL | TABLET | ADJPH |
| ORAL | TABLET, EXTENDED RELEASE | 1.33 MG |
| ORAL | TABLET, FILM COATED | ADJ PH |
| OTIC | SUSPENSION | ADJPH |
| PARENTERAL | INJECTION | ADJPH |
| PARENTERAL | KIT | ADJPH |
| PARENTERAL | LIQUID, WATER, STERILE, FOR INJECTION | ADJPH |
| PARENTERAL | POWDER, FOR INJECTION SOLUTION | ADJPH |
| PERFUSION, CARDIAC | SOLUTION | ADJPH |
| PERIDURAL | INJECTION | ADJPH |
| PERINEURAL | INJECTION | ADJ PH |
| PERINEURAL | INJECTION | NA |
| PERIODONTAL | GEL | NA |
| RECTAL | LIQUID | ADJPH |
| RECTAL | SOLUTION | ADJPH |
| RESPIRATORY (INHALATION) | SOLUTION | ADJPH |
| RESPIRATORY (INHALATION) | SOLUTION, FOR INHALATION | ADJPH |
| RESPIRATORY (INHALATION) | SPRAY | NA |
| RETROBULBAR | INJECTION | ADJPH |
| SOFT TISSUE | INJECTABLE | ADJPH |
| SOFT TISSUE | INJECTION | ADJPH |
| SOFT TISSUE | INJECTION, SUSTAINED ACTION | ADJPH |
| SOFT TISSUE | SUSPENSION, INJECTION | ADJPH |
| SPINAL | INJECTABLE | ADJPH |
| SPINAL | INJECTION | ADJPH |
| SUBARACHNOID | SOLUTION, INJECTION | ADJPH |
| SUBCONJUNCTIVAL | INJECTION | ADJPH |
| SUBCUTANEOUS | INJECTABLE | ADJPH |
| SUBCUTANEOUS | INJECTION | 0.17 % |
| SUBCUTANEOUS | INJECTION | ADJ PH |
| SUBCUTANEOUS | INJECTION, SOLUTION | ADJ PH |
| SUBCUTANEOUS | INJECTION, SOLUTION | ADJPH |
| SUBCUTANEOUS | POWDER, FOR INJECTION SOLUTION | ADJPH |
| SUBCUTANEOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | NA |
| SUBCUTANEOUS | SOLUTION | ADJ PH |
| SUBCUTANEOUS | SOLUTION, INJECTION | 0.61 % |
| SUBCUTANEOUS | SUSPENSION | ADJPH |
| SUBCUTANEOUS | SUSPENSION, INJECTION | 0.073 % |
| SUBMUCOSAL | INJECTION | ADJPH |
| SUBMUCOSAL | SOLUTION, INJECTION | ADJPH |
| TOPICAL | CREAM | 0.033 %W/W |
| TOPICAL | EMULSION | NA |
| TOPICAL | EMULSION, AEROSOL FOAM | NA |
| TOPICAL | EMULSION, CREAM | 0.01 %W/W |
| TOPICAL | GEL | 0.5 %W/W |
| TOPICAL | GEL | ADJPH |
| TOPICAL | JELLY | NA |
| TOPICAL | LOTION | NA |
| TOPICAL | OINTMENT | NA |
| TOPICAL | SHAMPOO | 4 %W/W |
| TOPICAL | SOLUTION | 0.31 %W/V |
| TOPICAL | SOLUTION | ADJ PH |
| TOPICAL | SOLUTION, DROPS | ADJPH |
| TOPICAL | SOLUTION/DROPS | NA |
| TOPICAL | SPONGE | NA |
| TOPICAL | SUSPENSION | NA |
| TRANSDERMAL | GEL | 0.024 % |
| URETERAL | SOLUTION | ADJPH |
| URETHRAL | INJECTION | ADJPH |
| URETHRAL | SOLUTION | ADJPH |